Cardiff School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, Wales, UK.
Renal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
Int J Clin Pharm. 2023 Feb;45(1):4-16. doi: 10.1007/s11096-022-01466-9. Epub 2022 Oct 28.
Treatment for people with kidney disease is often associated with complicated combinations of medicines. Logistical challenges with traditiona paper-based prescribing means that these patients are particularly susceptible to medication-relation errors and harm.
To improve the quality of care that people with kidney disease receive across Wales through a Value-Based digital transformation programme.
Renal units within the National Welsh Renal Clinical Network (WRCN).
A novel Electronic Prescribing & Medicines Administration (EPMA) system, integrated into a patient care record and linked to a patient portal was developed in South West Wales (SWW) region of the WRCN, enabled by the Welsh Government (WG) Efficiency Through Technology Fund. National upscale was enabled through the WG Transformation Fund.
EPMA was designed and rolled out initially in SWW region of the WRCN (2018). A dedicated delivery team used the blueprint to finalise and implement a strategy for successful national roll-out eventually across all Wales (completed 2021).
A multi-factorial approach was employed, as both the technology itself and the healthcare system within which it would be introduced, were complex. Continuous cycles of action research involving informal and formal qualitative interviews with service-users ensured that EPMA was accessible and optimally engaging to all target stakeholders (patients and staff). Results confirmed that EPMA was successful in improving the quality of care that people with kidney disease receive across Wales, contributed to Value-Based outcomes, and put people who deliver and access care at the heart of transformation.
Key findings of this study align directly with the national design principles to drive change and transformation, put forward by the WG in their plan for Health and Social Care: prevention and early intervention; safety; independence; voice; seamless care.
治疗肾病患者的方法常涉及复杂的药物组合。传统纸质处方带来的后勤挑战意味着这些患者特别容易发生药物相关错误和伤害。
通过基于价值的数字化转型计划,改善威尔士各地肾病患者的护理质量。
国家威尔士肾脏临床网络(WRCN)内的肾脏科。
在 WRCN 的西南威尔士(SWW)地区,开发了一种新颖的电子处方和药物管理(EPMA)系统,该系统集成到患者护理记录中,并与患者门户连接,该系统由威尔士政府(WG)的技术效率基金资助。通过 WG 转型基金实现了全国范围的推广。
EPMA 最初在 WRCN 的 SWW 地区设计并推出(2018 年)。一个专门的交付团队使用蓝图来完成并实施一项成功的全国推广战略,最终覆盖整个威尔士(2021 年完成)。
由于技术本身和引入技术的医疗保健系统都很复杂,因此采用了多因素方法。服务使用者的非正式和正式定性访谈的持续行动研究循环确保了 EPMA 对所有目标利益相关者(患者和工作人员)都具有可访问性和最佳参与度。结果证实,EPMA 成功改善了威尔士各地肾病患者的护理质量,有助于实现基于价值的结果,并将提供和获取护理的人置于转型的核心。
本研究的主要发现与 WG 在其卫生和社会保健计划中提出的推动变革和转型的国家设计原则直接一致:预防和早期干预;安全;独立;声音;无缝护理。